ILK, integrin linked kinase, 3611

N. diseases: 192; N. variants: 0
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.090 AlteredExpression disease BEFREE Differential expressions of integrin-linked kinase, β-parvin and cofilin 1 in high-fat diet induced prostate cancer progression in a transgenic mouse model. 30250560 2018
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.090 Biomarker disease BEFREE In order to test our hypothesis, DU145 and PC3B1 prostate cancer and MDA-MB-231 breast cancer cell lines were treated with small interfering RNA targeting actin and the intracellular signaling regulators focal adhesion kinase (FAK), integrin linked kinase (ILK), and paxillin. 25450398 2014
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.090 Biomarker disease BEFREE Loss of expression of the intracellular focal adhesion signaling effectors talin-1 and integrin linked kinase (ILK) sensitized human prostate cancer to anoikis. 24497940 2014
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.090 Biomarker disease BEFREE Thus, ILK is suggested to serve as a potential therapeutic target for PCa. 23783575 2013
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.090 AlteredExpression disease BEFREE Inhibition of ILK expression or activity inhibits centrosome clustering in several breast and prostate cancer cell lines that have centrosome amplification. 20838383 2011
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.090 Biomarker disease BEFREE Depletion of ILK and rictor in breast and prostate cancer cell lines resulted in inhibition of Akt Ser(473) phosphorylation and induction of apoptosis, whereas, in several cell lines, depletion of mTOR increased Akt phosphorylation. 18339839 2008
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.090 AlteredExpression disease BEFREE Integrin-linked kinase (ILK) has been shown to regulate PKB/Akt activity with the loss of PTEN in prostate cancer. 15782140 2005
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.090 Biomarker disease BEFREE We used an adenovirus-mediated approach to overexpress the ILK gene in a prostate cancer cell line and examine its effects on heat stress-induced cell death. 12631621 2003
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.090 Biomarker disease BEFREE Transfection of a kinase-deficient, dominant-negative form of ILK or exposure to a small molecule ILK inhibitor suppresses the constitutive phosphorylation of PKB/Akt on Ser-473, but not on Thr-308, in the PTEN-mutant prostate carcinoma cell lines PC-3 and LNCaP. 10716737 2000